Explore how using support tools can prevent treatment overutilization.
Telephonic and personalized diabetes self-education programs which fit into patient’s busy lives will make a greater impact than in-person classes only.
While the second feed may not change providers’ actions in terms of the strategy they’re implementing for the Comprehensive Care for Joint Replacement program, the findings should change their expectations.
Adding non-opioid postsurgical options to hospital formularies should be a top consideration.
Deaths due to opioid abuse have risen sharply-and show no signs of leveling off. Here’s how data analytics can prevent abuse and diversion.
Although CMS released the final rule for MACRA in October, there is still quite a bit of confusion.
Here’s what managed healthcare executives should keep an eye on moving into the new year.
By deploying a proactive, year-round strategy that aligns data analytics with a focused approach for addressing gaps in care, your organization can turn routine quality measurement and reporting activities into a true strategic advantage by ensuring that quality measurably improves across key metrics.
Here’s what managed healthcare executives should keep an eye on moving into the new year.
Here’s what managed healthcare executives should keep an eye on moving into the new year.
Because the imaging industry has been under a microscope for years, it's had to do more with less. There are many ways in which imaging can serve as a blueprint for other stakeholders as healthcare moves toward value-based care delivery models.
Beyond the obvious training and work flow challenges associated with the ICD-10 transition, a whole host of challenges will arise as ICD-10 becomes the new reality.
A nationwide interoperability roadmap released by the U.S. Department of Health and Human Services in January outlines a set of critical actions healthcare players need to take between now and 2024 to get to a fax machine-free future.
Consumer-driven healthcare has transformed from media buzzword to meaningful action, but it’s the economics behind the healthcare universe that have finally turned the consumer-driven concept into a reality for benefits administrators, employers and consumers alike.
Americans have been diagnosed with diabetes, mostly with the type 2 variety linked with being overweight or obese.
U.S. cities are home to 62.7% of the American population, according to the U.S. Census Bureau. This number is expected to grow to 87.4% by 2050. Here's how healthcare can keep up.
Beyond the obvious training and work flow challenges associated with the ICD-10 transition, a whole host of challenges will arise as ICD-10 becomes the new reality.
CVS Health is integrating HHS' Healthfinder.gov app into its web space under the name myHealthFinder.
Beyond the obvious training and work flow challenges associated with the ICD-10 transition, a whole host of challenges will arise as ICD-10 becomes the new reality.
The industry is awaiting the Supreme Court’s ruling on Universal Health Services v. Escobar. This case concerns the viability of the “implied certification” theory of legal falsity under the False Claims Act.
Executives of Medicare managed plans can benefit from knowing the challenges of the Medical Loss Ratio, a key cost control tool that went into effect last year.
Executives of Medicare managed plans can benefit from knowing the challenges of the Medical Loss Ratio, a key cost control tool that went into effect last year.
There is no one way a leader may develop, but there are three qualities that effective leaders possess.
Executives of Medicare managed plans can benefit from knowing the challenges of the Medical Loss Ratio, a key cost control tool that went into effect last year.
The conference raised important points about unregulated growth opportunities and new pharmacy arena players.
Any day now, the Supreme Court will decide the highly anticipated King v. Burwell, which will determine the viability of a central mechanism of the Affordable Care Act.
The next stage of chronic care management and value-based insurance design for the continuing onslaught of high-priced specialty drugs, including PCSK9 inhibitors.
A recent survey reveals how hospital technology budgets are changing. Find out if your organization is making similar changes.
An ongoing challenge particular to plans serving duals is a gap between the plans’ reimbursement rates and the health status of the populations they serve.